CClinicalTrials.gg
Status unknownNCT03263169Updated Aug 28, 2017

Community-based Personalized Care and QOL

An observational study in Aging and Disability or Chronic Disease Leading to Disablement, sponsored by Windsor-Essex Compassionate Care Community. Status unknown at 1 site in Canada. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-08-28.

Sponsored by Windsor-Essex Compassionate Care Community · Observational

The sponsor has not verified this record recently (last verified Aug 2017), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,100
Ages
65 Years and older
Sex
All
01

Study summary

A pragmatic randomized trial to evaluate the impact of an integrated patient experience and outcome measurement system supported by citizens, caregivers and community through eHealth technology.

The primary research question is: What is the effectiveness of the WECCC approach on quality of life in people aged 65 and older or who self-identify as disabled compared to people not receiving the Health TAPESTRY program?

Read the detailed description

Secondary research questions include:

  1. what is the feasibility of obtaining study measures through routinely collected program participant data and what design adjustments are needed to balance pragmatism and high quality data collection?
  2. What are the analytic approaches to be developed to aggregate data from individual participants into meaningful units (e.g. care-team level, organizational level, social network, and geographic area) to inform ongoing adaptation of the components of the intervention?
  3. what are the perceptions of knowledge users on the usefulness of comparative effectiveness pragmatic trial evidence?

The project involves using administrative data from the ICES to create outcome measures and feedback systems for communities, and the INSPIRE PHC Unit for expertise in health system integration, care in the community, and knowledge translation.

Inclusion criteria: Seniors (65+) and people who self-identify as having a functional disability. Pilot study sites: 7 municipalities and the city of Windsor in Windsor-Essex County in Ontario. The combined total eligible population in all 8 sites is about 60,000 people, from which a minimum sample of 3000 registered patients and 1000 registered caregivers will be drawn

In Year 1, planned enrolment includes a minimum of 1100 intervention clients from all recruitment methods in the care model intervention, with similar numbers of control and intention to treat clients.

The primary outcomes are quality of life (QOL); perceived health; experience of care, and perceived social connection.

The primary outcomes for caregivers will be quality of life; perceived burden; caregiver perceptions of care; and perceived social connection.

Secondary outcomes for both will include goal attainment, distress management, symptom management, places of care, and health care utilization and costs. In terms of health equity, the investigators will measure the difference between the average/median population quality of life and cost outcomes compared to patients at the bottom income quartiles stratified by risk level. At a systems level, algorithms will be developed and applied to the data collected from participants to provide aggregate organization and system-level reports, co-designed with end users to support them as learning organizations.

02

Conditions studied

  • Aging
  • Disability or Chronic Disease Leading to Disablement

Browse trials for

Keywords

  • e-health, community networks, pragmatic RCT
03

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Seniors who identify with having a functional disability or serious chronic disease; and informal caregivers. Many patients within this broad target population will be at risk of worsening quality of life or escalating health care utilization now or in the future due to aging, disease progression, or unmet health, social or economic needs.

Inclusion criteria

Individuals who:

  1. are 65 years of age and over
  2. have a long-term disability or one or more chronic diseases
  3. able to communicate in English OR can provide a formal or informal translator willing to facilitate the participant's involvement

Exclusion criteria

Exclusion Criteria:

Individuals not meeting above criteria

04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,100 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Groups and cohorts

  • WE Health Tapestry

    Completion of baseline measures then enrolled in a community-based personalized care intervention that consists of four core elements: volunteer support, interprofessional care, technology, social network linkage

    Behavioral: Community-based personalized care

  • Usual Care

    Completion of baseline measures with six-month delayed community-based personalized care intervention: volunteer support, interprofessional care, technology, social network linkage

    Behavioral: Community-based personalized care

Interventions

  • BehavioralCommunity-based personalized care

    volunteer support, health technology, interprofessional care, social network linkage

05

What researchers measure

Primary outcomes

  1. Quality of Life

    McGill QoL - patient and family

    Time frame: Baseline and then monthly for 24 months

  2. Perceived health

    EQ-5D-5L - patient

    Time frame: Baseline and then monthly for 24 months

Secondary outcomes

  1. Caregiver Burden 1

    InterRAI-home care

    Time frame: Baseline and then monthly for 24 months

  2. Caregiver Burden 2

    Zarit burden interview

    Time frame: Baseline and then monthly for 24 months

  3. Patient experience

    CANHelp Patient

    Time frame: Baseline and then monthly for 24 months

  4. Family experience

    CANHelp Family

    Time frame: Baseline and then monthly for 24 months

  5. Symptom management 1

    Edmonton Symptom Assessment Scale

    Time frame: Baseline and then monthly for 24 months

  6. Symptom management 2

    Palliative Performance Scale

    Time frame: Baseline and then monthly for 24 months

  7. Symptom management 3

    InterRAI-home care

    Time frame: Baseline and then monthly for 24 months

  8. Health services utilization 1

    hospitalization

    Time frame: Baseline and then monthly for 24 months

  9. Health services utilization 2

    Emergency care

    Time frame: Baseline and then monthly for 24 months

06

Study locations

1 of 1 sites recruiting
  • Windsor-Essex Compassionate Care Community Program Management Office
    Windsor, Ontario N8T 1B5, Canada
    • Deborah Sattler · Contact · deborah@deborahsattler.ca · 519-974-2581
    • Diane Halbgewachs · Contact · DHalbgewachs2@thehospice.ca · 519-974-2581
    • Michelle Howard, PhD · Principal investigator
    • Lisa Dolovich, PhD · Sub investigator
    • Kathryn Pfaff, PhD · Sub investigator
    • Merrick Zwarenstein, PhD · Sub investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03263169
Lead sponsor
Windsor-Essex Compassionate Care Community
Collaborators
University of Windsor, McMaster University, University of Western Ontario, Canada, Green Shield Canada Inc., Erie St. Clair Local Health Integration Network (LHIN)
Responsible party
Sponsor
First posted
Aug 28, 2017
Start date
Jul 1, 2017
Primary completion
Sep 30, 2018 (estimated)
Completion
Sep 30, 2018 (estimated)
Last update
Aug 28, 2017

Study contacts

Deborah Sattler
Contact
deborah@deborahsattler.ca
974-2581 ext. 2420
Kathryn A Pfaff, PhD
Contact
kpfaff@uwindsor.ca
253-3000 ext. 4977
Michelle Howard, PhD
principal investigator · McMaster University
Lisa Dolovich, PhD
principal investigator · McMaster University
Kathryn Pfaff, PhD
principal investigator · University of Windsor

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion